Anthony J. Cannon, MD, FACE

4.90 out of 5 (51 ratings, 9 reviews)
Ratings and Reviews

Departments

Cooper University Health Care Titles

  • Endocrinologist

Cooper Medical School of Rowan University Titles

  • Clinical Associate Professor of Medicine

Board Certifications

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Endocrinology, Diabetes, and Metabolism)

Professional Type

Cooper Care Alliance

NPI

1831259340

Office Locations

Cherry Hill
Cooper Care Alliance at Brace Road

1210 Brace Road
Cherry Hill , NJ 08034
Phone: 856.536.1515
Maps & Directions

Education & Training

Medical SchoolCornell University, New York, NY
InternshipInternal Medicine - Hartford Hospital, Hartford, CT
ResidencyInternal Medicine - Baystate Medical Center, Springfield, MA
FellowshipEndocrinology, Temple University Hospital, Philadelphia, PA

Memberships

  • American Diabetes Association
  • National Medical Association
  • Thyroid Club of South Jersey
  • American Association of Clinical Endocrinologists (AACE)

Awards and Honors

  • Recipient, American Diabetes Association Chair’s Citation Award - 2015
  • Fellow, American College of Endocrinology, FACE - 2012

Publications

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Handelsman Y, Wyne K, Cannon A, Shannon M, Schneider D. Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S14-S29. doi: 10.18553/jmcp.2018.24.9-a.s14. Erratum in: J Manag Care Spec Pharm. 2018 Nov;24(11):1196a. PMID: 30156445.

Heile M, Wyne K, Billings LK, Cannon A, Handelsman Y, Shannon M. Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S42-S52. doi: 10.18553/jmcp.2018.24.9-a.s42. PMID: 30156446.

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Shomali ME, Ørsted DD, Cannon AJ. Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials. Diabet Med. 2017 Feb;34(2):197-203. doi: 10.1111/dme.13185. Epub 2016 Aug 16. PMID: 27412701; PMCID: PMC5248619.

Ard J, Cannon A, Lewis CE, Lofton H, Vang Skjøth T, Stevenin B, Pi-Sunyer X. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials. Diabetes Obes Metab. 2016 Apr;18(4):430-5. doi: 10.1111/dom.12632. Epub 2016 Feb 11. PMID: 26744025; PMCID: PMC6084344.

Peyrot M, Egede LE, Campos C, Cannon AJ, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Curr Med Res Opin. 2014 Nov;30(11):2241-54. doi: 10.1185/03007995.2014.947023. Epub 2014 Aug 18. PMID: 25079662.

Mehta JM, Miller JL, Cannon AJ, Mardekian SK, Kenyon LC, Jabbour SA. Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman. Case Rep Endocrinol. 2014;2014:762745. doi: 10.1155/2014/762745. Epub 2014 Jun 19. PMID: 25045549; PMCID: PMC4089940.

Cannon AJ. Delivering culturally competent care in clinical practice: a call to action. J Natl Med Assoc. 2012 Jan-Feb;104(1-2):104-7. doi: 10.1016/s0027-9684(15)33514-8. PMID: 22708254.

Ratings and Reviews

Ratings and reviews come from patient responses to health care provider-related questions on the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Patient Experience Survey that Cooper sends to patients after outpatient office visits.  Learn more about our survey and how ratings are calculated >>

Overall Rating

4.90 out of 5 (51 ratings, 9 reviews)
Apr 12, 2025
Dr Cannon in my opinion is the best Doctor i ever had. He has my diabetes under control. My health is so much better thanks to Dr Cannon.
Apr 12, 2025
Dr Cannon always makes me feel like I'm unique. Thanks for caring
Mar 12, 2025
My favorite Doctor.
Mar 12, 2025
Dr Cannon and his staff are excellent.
Mar 12, 2025
Dr. Cannon is an excellent doctor and truly cares about his patients. Thank you for having him there.
Mar 12, 2025
Talks to fast for me to fully understand. I don't know medical jargon and what some numbers mean.
Feb 12, 2025
The staff is very friendly and efficient. Dr Cannon is the best. He explains everything to me and always shows graphs of my test results.
Feb 12, 2025
Dr Cannon is very knowledgeable and is helping me to gain control of my diabetes. My sugars were out of control until I saw Dr Cannon and now is better controlled with his guidance
Feb 12, 2025
Dr Cannon absolutely the best.